BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23296613)

  • 1. Measuring binding of S100 proteins to RAGE by surface plasmon resonance.
    Leclerc E
    Methods Mol Biol; 2013; 963():201-13. PubMed ID: 23296613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
    Mohan SK; Gupta AA; Yu C
    Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins--potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivo.
    Hoppmann S; Haase C; Richter S; Pietzsch J
    Protein Expr Purif; 2008 Feb; 57(2):143-52. PubMed ID: 18039581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
    Rani SG; Sepuru KM; Yu C
    Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
    Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
    J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-affinity immobilization of proteins using biotin- and GST-based coupling strategies.
    Hutsell SQ; Kimple RJ; Siderovski DP; Willard FS; Kimple AJ
    Methods Mol Biol; 2010; 627():75-90. PubMed ID: 20217614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intact-cell-based surface plasmon resonance measurements for ligand affinity evaluation of a membrane receptor.
    Mizuguchi T; Uchimura H; Kataoka H; Akaji K; Kiso Y; Saito K
    Anal Biochem; 2012 Jan; 420(2):185-7. PubMed ID: 22005322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Allmen EU; Koch M; Fritz G; Legler DF
    Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capture of the human IgG1 antibodies by protein A for the kinetic study of h-IgG/FcγR interaction using SPR-based biosensor technology.
    Champion T; Beck A
    Methods Mol Biol; 2013; 988():331-43. PubMed ID: 23475730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
    Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
    Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of S100 proteins to RAGE: an update.
    Leclerc E; Fritz G; Vetter SW; Heizmann CW
    Biochim Biophys Acta; 2009 Jun; 1793(6):993-1007. PubMed ID: 19121341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain.
    Khan MI; Su YK; Zou J; Yang LW; Chou RH; Yu C
    PLoS One; 2018; 13(2):e0190545. PubMed ID: 29444082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
    Donato R
    Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutical production: Applications of surface plasmon resonance biosensors.
    Thillaivinayagalingam P; Gommeaux J; McLoughlin M; Collins D; Newcombe AR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):149-53. PubMed ID: 19762290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
    Penumutchu SR; Chou RH; Yu C
    PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface plasmon resonance biosensor for direct detection of antibodies against human growth hormone.
    Kausaite-Minkstimiene A; Ramanaviciene A; Ramanavicius A
    Analyst; 2009 Oct; 134(10):2051-7. PubMed ID: 19768212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
    Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
    J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput kinase assay based on surface plasmon resonance.
    Takeda H; Goshima N; Nomura N
    Methods Mol Biol; 2010; 627():131-45. PubMed ID: 20217618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-free, real-time interaction and adsorption analysis 1: surface plasmon resonance.
    Fee CJ
    Methods Mol Biol; 2013; 996():287-312. PubMed ID: 23504431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface plasmon resonance spectroscopy for characterisation of membrane protein-ligand interactions and its potential for drug discovery.
    Patching SG
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt A):43-55. PubMed ID: 23665295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.